O	O	0	1	A	A	B-NP	DT	O	3	NMOD	O
O	O	2	7	novel	novel	I-NP	JJ	O	3	NMOD	O
O	O	8	26	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	7	NMOD	O
O	O	26	27	-	-	B-NP	HYPH	O	3	P	O
O	O	27	34	induced	induce	I-NP	VBN	O	7	NMOD	O
O	O	35	48	transcription	transcription	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	49	55	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	56	66	regulating	regulate	B-VP	VBG	O	7	NMOD	O
T1	B-Protein	67	72	tumor	tumor	B-NP	NN	B-protein	14	NMOD	B-protein
T1	I-Protein	73	81	necrosis	necrosis	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Protein	82	88	factor	factor	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Protein	89	94	alpha	alpha	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	95	99	gene	gene	I-NP	NN	O	14	NMOD	O
O	O	100	110	expression	expression	I-NP	NN	O	8	OBJ	O
O	O	110	111	:	:	O	:	O	7	P	O
O	O	112	121	molecular	molecular	B-NP	JJ	O	17	NMOD	O
O	O	122	129	cloning	cloning	I-NP	NN	O	25	NMOD	O
O	O	129	130	,	,	O	,	O	25	P	O
O	O	131	141	sequencing	sequencing	B-NP	NN	O	25	NMOD	O
O	O	141	142	,	,	O	,	O	25	P	O
O	O	143	159	characterization	characterization	B-NP	NN	O	25	NMOD	O
O	O	159	160	,	,	O	,	O	25	P	O
O	O	161	164	and	and	O	CC	O	25	NMOD	O
O	O	165	176	chromosomal	chromosomal	B-NP	JJ	O	25	NMOD	O
O	O	177	187	assignment	assignment	I-NP	NN	O	0	ROOT	O
O	O	187	188	.	.	O	.	O	25	P	O

O	O	190	208	Lipopolysaccharide	Lipopolysaccharide	B-NP	NN	O	5	SUB	O
O	O	209	210	(	(	O	(	O	4	DEP	O
O	O	210	213	LPS	LPS	B-NP	NN	O	4	DEP	O
O	O	213	214	)	)	O	)	O	1	NMOD	O
O	O	215	217	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	218	219	a	a	B-NP	DT	O	8	NMOD	O
O	O	220	226	potent	potent	I-NP	JJ	O	8	NMOD	O
O	O	227	237	stimulator	stimulator	I-NP	NN	O	5	PRD	O
O	O	238	240	of	of	B-PP	IN	O	8	NMOD	O
O	O	241	250	monocytes	monocyte	B-NP	NNS	B-cell_type	12	NMOD	B-cell_type
O	O	251	254	and	and	O	CC	O	12	NMOD	O
O	O	255	266	macrophages	macrophage	B-NP	NNS	B-cell_type	9	PMOD	B-cell_type
O	O	266	267	,	,	O	,	O	8	P	O
O	O	268	275	causing	cause	B-VP	VBG	O	8	NMOD	O
O	O	276	285	secretion	secretion	B-NP	NN	O	14	OBJ	O
O	O	286	288	of	of	B-PP	IN	O	15	NMOD	O
T2	B-Protein	289	294	tumor	tumor	B-NP	NN	B-protein	20	NMOD	B-protein
T2	I-Protein	295	303	necrosis	necrosis	I-NP	NN	I-protein	20	NMOD	I-protein
T2	I-Protein	304	310	factor	factor	I-NP	NN	I-protein	20	NMOD	I-protein
T2	I-Protein	311	316	alpha	alpha	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	317	318	(	(	O	(	O	25	DEP	O
T3	B-Protein	318	321	TNF	TNF	B-NP	NN	B-protein	24	NMOD	B-protein
T3	I-Protein	321	322	-	-	O	HYPH	I-protein	24	P	I-protein
T3	I-Protein	322	327	alpha	alpha	B-NP	SYM	I-protein	25	DEP	I-protein
O	O	327	328	)	)	O	)	O	20	NMOD	O
O	O	329	332	and	and	O	CC	O	29	NMOD	O
O	O	333	338	other	other	B-NP	JJ	O	29	NMOD	O
O	O	339	351	inflammatory	inflammatory	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	352	361	mediators	mediator	I-NP	NNS	I-protein	16	PMOD	I-protein
O	O	361	362	.	.	O	.	O	5	P	O

O	O	363	368	Given	Give	B-PP	VBN	O	14	VMOD	O
O	O	369	372	the	the	B-NP	DT	O	4	NMOD	O
O	O	373	384	deleterious	deleterious	I-NP	JJ	O	4	NMOD	O
O	O	385	392	effects	effect	I-NP	NNS	O	1	PMOD	O
O	O	393	395	to	to	B-PP	TO	O	4	NMOD	O
O	O	396	399	the	the	B-NP	DT	O	7	NMOD	O
O	O	400	404	host	host	I-NP	NN	O	5	PMOD	O
O	O	405	407	of	of	B-PP	IN	O	7	NMOD	O
T4	B-Protein	408	411	TNF	TNF	B-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Protein	411	412	-	-	O	HYPH	O	11	P	O
T4	I-Protein	412	417	alpha	alpha	B-NP	SYM	O	8	PMOD	O
O	O	417	418	,	,	O	,	O	14	P	O
O	O	419	421	it	it	B-NP	PRP	O	14	SUB	O
O	O	422	425	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	426	430	been	be	I-VP	VBN	O	14	VC	O
O	O	431	441	postulated	postulate	I-VP	VBN	O	15	VC	O
O	O	442	446	that	that	B-SBAR	IN	O	16	VMOD	O
T5	B-Protein	447	450	TNF	TNF	B-NP	NN	B-protein	22	NMOD	B-protein
T5	I-Protein	450	451	-	-	O	HYPH	O	22	NMOD	O
T5	I-Protein	451	456	alpha	alpha	O	SYM	O	22	NMOD	O
O	O	457	461	gene	gene	B-NP	NN	O	22	NMOD	O
O	O	462	472	expression	expression	I-NP	NN	O	23	SUB	O
O	O	473	477	must	must	B-VP	MD	O	17	SBAR	O
O	O	478	480	be	be	I-VP	VB	O	23	VC	O
O	O	481	488	tightly	tightly	I-VP	RB	O	24	VMOD	O
O	O	489	498	regulated	regulate	I-VP	VBN	O	24	VC	O
O	O	498	499	.	.	O	.	O	14	P	O

O	O	500	503	The	The	B-NP	DT	O	2	NMOD	O
O	O	504	510	nature	nature	I-NP	NN	O	19	SUB	O
O	O	511	513	of	of	B-PP	IN	O	2	NMOD	O
O	O	514	517	the	the	B-NP	DT	O	8	NMOD	O
O	O	518	525	nuclear	nuclear	I-NP	JJ	B-protein	8	NMOD	B-protein
O	O	526	532	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	532	533	(	(	I-NP	(	O	8	NMOD	O
O	O	533	534	s	s	I-NP	NNS	O	3	PMOD	O
O	O	534	535	)	)	O	)	O	8	NMOD	O
O	O	536	540	that	that	B-NP	WDT	O	8	NMOD	O
O	O	541	548	control	control	B-VP	VBP	O	10	SBAR	O
T6	B-Protein	549	552	TNF	TNF	B-NP	NN	B-protein	16	NMOD	B-protein
T6	I-Protein	552	553	-	-	B-NP	HYPH	O	16	P	O
T6	I-Protein	553	558	alpha	alpha	I-NP	SYM	O	16	NMOD	O
O	O	559	563	gene	gene	I-NP	NN	O	16	NMOD	O
O	O	564	577	transcription	transcription	I-NP	NN	O	11	OBJ	O
O	O	578	580	in	in	B-PP	IN	O	16	NMOD	O
O	O	581	587	humans	human	B-NP	NNS	O	17	PMOD	O
O	O	588	595	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	596	603	obscure	obscure	B-ADJP	JJ	O	19	PRD	O
O	O	603	604	,	,	O	,	O	19	P	O
O	O	605	613	although	although	B-SBAR	IN	O	19	VMOD	O
T17	B-Entity	614	616	NF	NF	B-NP	NN	B-protein	25	NMOD	B-protein
T17	I-Entity	616	617	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T17	I-Entity	617	623	kappaB	kappaB	I-NP	NN	I-protein	26	SUB	I-protein
O	O	624	627	has	have	B-VP	VBZ	O	22	SBAR	O
O	O	628	632	been	be	I-VP	VBN	O	26	VC	O
O	O	633	642	suggested	suggest	I-VP	VBN	O	27	VC	O
O	O	642	643	.	.	O	.	O	19	P	O

O	O	644	647	Our	Our	B-NP	PRP$	O	3	NMOD	O
O	O	648	656	previous	previous	I-NP	JJ	O	3	NMOD	O
O	O	657	664	studies	study	I-NP	NNS	O	10	SUB	O
O	O	665	675	pertaining	pertain	B-VP	VBG	O	3	NMOD	O
O	O	676	678	to	to	B-PP	TO	O	4	VMOD	O
O	O	679	689	macrophage	macrophage	B-NP	NN	O	7	NMOD	O
O	O	690	698	response	response	I-NP	NN	O	5	PMOD	O
O	O	699	701	to	to	B-PP	TO	O	7	NMOD	O
O	O	702	705	LPS	LPS	B-NP	NN	O	8	PMOD	O
O	O	706	716	identified	identify	B-VP	VBD	O	0	ROOT	O
O	O	717	718	a	a	B-NP	DT	O	16	NMOD	O
O	O	719	724	novel	novel	I-NP	JJ	O	16	NMOD	O
T18	B-Entity	725	728	DNA	DNA	I-NP	NN	B-protein	16	NMOD	B-protein
T18	I-Entity	728	729	-	-	B-PP	HYPH	I-protein	16	NMOD	I-protein
T18	I-Entity	729	736	binding	bind	B-NP	VBG	I-protein	16	NMOD	I-protein
T18	I-Entity	737	743	domain	domain	I-NP	NN	I-protein	10	OBJ	I-protein
O	O	744	751	located	located	B-ADJP	JJ	O	16	NMOD	O
O	O	752	756	from	from	B-PP	IN	O	17	AMOD	O
O	O	757	758	-	-	B-NP	SYM	B-DNA	18	PMOD	B-DNA
O	O	758	761	550	550	I-NP	CD	I-DNA	19	NMOD	I-DNA
O	O	762	764	to	to	B-PP	TO	I-DNA	18	PMOD	I-DNA
O	O	765	766	-	-	B-NP	SYM	I-DNA	21	PMOD	I-DNA
O	O	766	769	487	487	I-NP	CD	I-DNA	22	NMOD	I-DNA
O	O	770	772	in	in	B-PP	IN	O	17	AMOD	O
O	O	773	776	the	the	B-NP	DT	O	30	NMOD	O
O	O	777	782	human	human	I-NP	JJ	B-DNA	30	NMOD	B-DNA
T7	B-Protein	783	786	TNF	TNF	I-NP	NN	I-DNA	30	NMOD	I-DNA
T7	I-Protein	786	787	-	-	I-NP	HYPH	I-DNA	30	NMOD	I-DNA
T7	I-Protein	787	792	alpha	alpha	I-NP	NN	I-DNA	30	NMOD	I-DNA
T19	B-Entity	793	801	promoter	promoter	I-NP	NN	I-DNA	24	PMOD	I-DNA
O	O	802	806	that	that	B-NP	WDT	O	30	NMOD	O
O	O	807	815	contains	contain	B-VP	VBZ	O	31	SBAR	O
O	O	816	831	transcriptional	transcriptional	B-NP	JJ	O	34	NMOD	O
O	O	832	840	activity	activity	I-NP	NN	O	32	OBJ	O
O	O	840	841	,	,	O	,	O	32	P	O
O	O	842	845	but	but	O	CC	O	32	VMOD	O
O	O	846	851	lacks	lack	B-VP	VBZ	O	32	VMOD	O
O	O	852	855	any	any	B-NP	DT	O	39	NMOD	O
O	O	856	861	known	know	I-NP	VBN	O	37	OBJ	O
T20,T21	B-Entity,B-Entity	862	864	NF	NF	I-NP	NN	B-protein	42	NMOD	B-protein
T20,T21	I-Entity,I-Entity	864	865	-	-	B-NP	HYPH	I-protein	42	NMOD	I-protein
T20,T21	I-Entity,I-Entity	865	871	kappaB	kappaB	I-NP	NN	I-protein	39	NMOD	I-protein
T20	I-Entity	871	872	-	-	B-VP	HYPH	O	45	NMOD	O
T20	I-Entity	872	879	binding	bind	B-NP	VBG	B-DNA	45	NMOD	B-DNA
T20	I-Entity	880	885	sites	site	I-NP	NNS	I-DNA	39	NMOD	I-DNA
O	O	885	886	.	.	O	.	O	10	P	O

O	O	887	889	We	We	B-NP	PRP	O	2	SUB	O
O	O	890	894	have	have	B-VP	VBP	O	0	ROOT	O
O	O	895	899	used	use	I-VP	VBN	O	2	VC	O
O	O	900	904	this	this	B-NP	DT	O	6	NMOD	O
O	O	905	908	DNA	DNA	I-NP	NN	B-DNA	6	NMOD	B-DNA
O	O	909	917	fragment	fragment	I-NP	NN	I-DNA	3	OBJ	I-DNA
O	O	918	920	to	to	B-VP	TO	O	8	VMOD	O
O	O	921	928	isolate	isolate	I-VP	VB	O	3	VMOD	O
O	O	929	932	and	and	I-VP	CC	O	8	VMOD	O
O	O	933	939	purify	purify	I-VP	VB	O	8	VMOD	O
O	O	940	941	a	a	B-NP	DT	O	15	NMOD	O
O	O	942	944	60	60	I-NP	CD	B-protein	15	NMOD	B-protein
O	O	944	945	-	-	I-NP	HYPH	I-protein	15	NMOD	I-protein
O	O	945	948	kDa	kDa	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	949	956	protein	protein	I-NP	NN	I-protein	8	VMOD	I-protein
O	O	957	964	binding	bind	B-VP	VBG	O	15	NMOD	O
O	O	965	967	to	to	B-PP	TO	O	16	VMOD	O
O	O	968	972	this	this	B-NP	DT	O	19	NMOD	O
O	O	973	981	fragment	fragment	I-NP	NN	O	17	PMOD	O
O	O	982	985	and	and	O	CC	O	3	VMOD	O
O	O	986	994	obtained	obtain	B-VP	VBN	O	3	VMOD	O
O	O	995	998	its	its	B-NP	PRP$	O	26	NMOD	O
T22	B-Entity	999	1004	amino	amino	I-NP	JJ	B-protein	26	NMOD	B-protein
T22	I-Entity	1004	1005	-	-	I-NP	HYPH	I-protein	26	NMOD	I-protein
T22	I-Entity	1005	1013	terminal	terminal	I-NP	JJ	I-protein	26	NMOD	I-protein
T22	I-Entity	1014	1022	sequence	sequence	I-NP	NN	I-protein	21	OBJ	I-protein
O	O	1022	1023	,	,	O	,	O	2	P	O
O	O	1024	1029	which	which	B-NP	WDT	O	2	VMOD	O
O	O	1030	1033	was	be	B-VP	VBD	O	28	SBAR	O
O	O	1034	1038	used	use	I-VP	VBN	O	29	VC	O
O	O	1039	1041	to	to	B-VP	TO	O	32	VMOD	O
O	O	1042	1048	design	design	I-VP	VB	O	30	VMOD	O
O	O	1049	1059	degenerate	degenerate	B-NP	JJ	B-DNA	34	NMOD	B-DNA
O	O	1060	1066	probes	probe	I-NP	NNS	I-DNA	32	OBJ	I-DNA
O	O	1067	1069	to	to	B-VP	TO	O	36	VMOD	O
O	O	1070	1076	screen	screen	I-VP	VB	O	34	NMOD	O
O	O	1077	1078	a	a	B-NP	DT	O	39	NMOD	O
T23	B-Entity	1079	1083	cDNA	cDNA	I-NP	NN	B-DNA	39	NMOD	B-DNA
T23	I-Entity	1084	1091	library	library	I-NP	NN	I-DNA	36	OBJ	I-DNA
O	O	1092	1096	from	from	B-PP	IN	O	36	VMOD	O
O	O	1097	1100	THP	THP	B-NP	NN	B-cell_line	44	NMOD	B-cell_line
O	O	1100	1101	-	-	B-NP	HYPH	I-cell_line	44	NMOD	I-cell_line
O	O	1101	1102	1	1	I-NP	CD	I-cell_line	44	NMOD	I-cell_line
O	O	1103	1108	cells	cell	I-NP	NNS	I-cell_line	40	PMOD	I-cell_line
O	O	1108	1109	.	.	O	.	O	2	P	O

O	O	1110	1111	A	A	B-NP	DT	O	4	NMOD	O
O	O	1112	1117	novel	novel	I-NP	JJ	O	4	NMOD	O
O	O	1118	1122	cDNA	cDNA	I-NP	NN	B-DNA	4	NMOD	B-DNA
O	O	1123	1128	clone	clone	I-NP	NN	I-DNA	11	SUB	I-DNA
O	O	1129	1130	(	(	O	(	O	10	DEP	O
O	O	1130	1131	1	1	B-NP	CD	O	10	DEP	O
O	O	1131	1132	.	.	O	.	O	10	DEP	O
O	O	1132	1133	8	8	B-NP	CD	O	9	NMOD	O
O	O	1134	1136	kb	kb	I-NP	NN	O	10	DEP	O
O	O	1136	1137	)	)	O	)	O	4	NMOD	O
O	O	1138	1141	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1142	1150	isolated	isolate	I-VP	VBN	O	11	VC	O
O	O	1151	1154	and	and	O	CC	O	12	VMOD	O
O	O	1155	1160	fully	fully	B-VP	RB	O	12	VMOD	O
O	O	1161	1170	sequenced	sequence	I-VP	VBN	O	12	VMOD	O
O	O	1170	1171	.	.	O	.	O	11	P	O

O	O	1172	1188	Characterization	Characterization	B-NP	NN	O	6	SUB	O
O	O	1189	1191	of	of	B-PP	IN	O	1	NMOD	O
O	O	1192	1196	this	this	B-NP	DT	O	5	NMOD	O
O	O	1197	1201	cDNA	cDNA	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	1202	1207	clone	clone	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	1208	1216	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	1217	1221	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	1222	1225	its	its	B-NP	PRP$	O	9	NMOD	O
O	O	1226	1235	induction	induction	I-NP	NN	O	10	SUB	O
O	O	1236	1239	was	be	B-VP	VBD	O	7	SBAR	O
O	O	1240	1249	dependent	dependent	B-ADJP	JJ	O	10	PRD	O
O	O	1250	1252	on	on	B-PP	IN	O	11	AMOD	O
O	O	1253	1256	LPS	LPS	B-NP	NN	O	14	NMOD	O
O	O	1257	1267	activation	activation	I-NP	NN	O	12	PMOD	O
O	O	1268	1270	of	of	B-PP	IN	O	14	NMOD	O
O	O	1271	1274	THP	THP	B-NP	NN	B-cell_line	19	NMOD	B-cell_line
O	O	1274	1275	-	-	B-NP	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	1275	1276	1	1	I-NP	CD	I-cell_line	19	NMOD	I-cell_line
O	O	1277	1282	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	1282	1283	;	;	O	:	O	6	P	O
O	O	1284	1289	hence	hence	B-ADVP	RB	O	6	VMOD	O
O	O	1289	1290	,	,	O	,	O	6	P	O
O	O	1291	1294	the	the	B-NP	DT	O	25	NMOD	O
O	O	1295	1299	name	name	I-NP	NN	O	25	NMOD	O
T8	B-Protein	1300	1303	LPS	LPS	I-NP	NN	O	31	NMOD	O
T8	I-Protein	1303	1304	-	-	B-VP	HYPH	O	31	P	O
T8	I-Protein	1304	1311	induced	induce	B-NP	VBN	O	31	NMOD	O
T8	I-Protein	1312	1315	TNF	TNF	I-NP	NN	B-protein	31	NMOD	B-protein
T8	I-Protein	1315	1316	-	-	O	HYPH	O	31	NMOD	O
T8	I-Protein	1316	1321	alpha	alpha	O	SYM	O	31	NMOD	O
T8	I-Protein	1322	1328	factor	factor	B-NP	NN	O	6	VMOD	O
O	O	1329	1330	(	(	O	(	O	34	DEP	O
T9	B-Protein	1330	1335	LITAF	LITAF	B-NP	NN	B-protein	34	DEP	B-protein
O	O	1335	1336	)	)	O	)	O	31	NMOD	O
O	O	1336	1337	.	.	O	.	O	6	P	O

O	O	1338	1348	Inhibition	Inhibition	B-NP	NN	O	11	SUB	O
O	O	1349	1351	of	of	B-PP	IN	O	1	NMOD	O
T10	B-Protein	1352	1357	LITAF	LITAF	B-NP	NN	B-RNA	5	NMOD	B-RNA
O	O	1358	1362	mRNA	mRNA	I-NP	NN	I-RNA	5	NMOD	I-RNA
O	O	1363	1373	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	1374	1376	in	in	B-PP	IN	O	5	NMOD	O
O	O	1377	1380	THP	THP	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	1380	1381	-	-	B-NP	HYPH	I-cell_line	10	NMOD	I-cell_line
O	O	1381	1382	1	1	I-NP	CD	I-cell_line	10	NMOD	I-cell_line
O	O	1383	1388	cells	cell	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	1389	1397	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	1398	1400	in	in	B-PP	IN	O	11	VMOD	O
O	O	1401	1402	a	a	B-NP	DT	O	14	NMOD	O
O	O	1403	1412	reduction	reduction	I-NP	NN	O	12	PMOD	O
O	O	1413	1415	of	of	B-PP	IN	O	14	NMOD	O
T11	B-Protein	1416	1419	TNF	TNF	B-NP	NN	B-protein	19	NMOD	B-protein
T11	I-Protein	1419	1420	-	-	B-NP	HYPH	O	19	P	O
T11	I-Protein	1420	1425	alpha	alpha	I-NP	SYM	B-RNA	19	NMOD	B-RNA
O	O	1426	1437	transcripts	transcript	B-NP	NNS	I-RNA	15	PMOD	I-RNA
O	O	1437	1438	.	.	O	.	O	11	P	O

O	O	1439	1441	In	In	B-PP	IN	O	11	VMOD	O
O	O	1442	1450	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	1450	1451	,	,	O	,	O	11	P	O
O	O	1452	1456	high	high	B-NP	JJ	O	5	NMOD	O
O	O	1457	1462	level	level	I-NP	NN	O	11	SUB	O
O	O	1463	1465	of	of	B-PP	IN	O	5	NMOD	O
O	O	1466	1476	expression	expression	B-NP	NN	O	6	PMOD	O
O	O	1477	1479	of	of	B-PP	IN	O	7	NMOD	O
T12	B-Protein	1480	1485	LITAF	LITAF	B-NP	NN	B-RNA	10	NMOD	B-RNA
O	O	1486	1490	mRNA	mRNA	I-NP	NN	I-RNA	8	PMOD	I-RNA
O	O	1491	1494	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1495	1503	observed	observe	I-VP	VBN	O	11	VC	O
O	O	1504	1517	predominantly	predominantly	B-ADVP	RB	O	12	VMOD	O
O	O	1518	1520	in	in	B-PP	IN	O	12	VMOD	O
O	O	1521	1524	the	the	B-NP	DT	O	27	NMOD	O
O	O	1525	1533	placenta	placenta	I-NP	NN	O	27	NMOD	O
O	O	1533	1534	,	,	O	,	O	27	P	O
O	O	1535	1545	peripheral	peripheral	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	1546	1551	blood	blood	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	1552	1562	leukocytes	leukocyte	I-NP	NNS	I-cell_type	27	NMOD	I-cell_type
O	O	1562	1563	,	,	O	,	O	27	P	O
O	O	1564	1569	lymph	lymph	B-NP	NN	O	23	NMOD	O
O	O	1570	1575	nodes	node	I-NP	NNS	O	27	NMOD	O
O	O	1575	1576	,	,	O	,	O	27	P	O
O	O	1577	1580	and	and	O	CC	O	27	NMOD	O
O	O	1581	1584	the	the	B-NP	DT	O	27	NMOD	O
O	O	1585	1591	spleen	spleen	I-NP	NN	O	14	PMOD	O
O	O	1591	1592	.	.	O	.	O	11	P	O

O	O	1593	1600	Finally	Finally	B-ADVP	RB	O	10	VMOD	O
O	O	1600	1601	,	,	O	,	O	10	P	O
O	O	1602	1613	chromosomal	chromosomal	B-NP	JJ	O	4	NMOD	O
O	O	1614	1626	localization	localization	I-NP	NN	O	10	SUB	O
O	O	1627	1632	using	use	B-VP	VBG	O	4	NMOD	O
O	O	1633	1645	fluorescence	fluorescence	B-NP	NN	O	9	NMOD	O
O	O	1646	1648	in	in	B-NP	FW	O	9	NMOD	O
O	O	1649	1653	situ	situ	I-NP	FW	O	9	NMOD	O
O	O	1654	1667	hybridization	hybridization	I-NP	NN	O	5	OBJ	O
O	O	1668	1676	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	1677	1681	that	that	B-SBAR	IN	O	10	VMOD	O
T13	B-Protein	1682	1687	LITAF	LITAF	B-NP	NN	B-protein	13	SUB	B-protein
O	O	1688	1694	mapped	map	B-VP	VBN	O	11	SBAR	O
O	O	1695	1697	to	to	B-PP	TO	O	13	VMOD	O
T24	B-Entity	1698	1708	chromosome	chromosome	B-NP	NN	B-DNA	17	NMOD	B-DNA
T24	I-Entity	1709	1714	16p12	16p12	I-NP	CD	I-DNA	15	NMOD	I-DNA
T24	I-Entity	1714	1715	-	-	I-NP	HYPH	O	14	PMOD	O
T24	I-Entity	1715	1720	16p13	16p13	I-NP	CD	B-DNA	17	NMOD	B-DNA
T24	I-Entity	1720	1721	.	.	I-NP	.	O	11	DEP	O
T24	I-Entity	1721	1722	3	3	I-NP	CD	O	19	OBJ	O
O	O	1722	1723	.	.	O	.	O	10	P	O

O	O	1724	1732	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	1732	1733	,	,	O	,	O	5	P	O
O	O	1734	1739	these	these	B-NP	DT	O	4	NMOD	O
O	O	1740	1748	findings	finding	I-NP	NNS	O	5	SUB	O
O	O	1749	1756	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1757	1761	that	that	B-SBAR	IN	O	5	VMOD	O
T14	B-Protein	1762	1767	LITAF	LITAF	B-NP	NN	B-protein	8	SUB	B-protein
O	O	1768	1773	plays	play	B-VP	VBZ	O	6	SBAR	O
O	O	1774	1776	an	an	B-NP	DT	O	11	NMOD	O
O	O	1777	1786	important	important	I-NP	JJ	O	11	NMOD	O
O	O	1787	1791	role	role	I-NP	NN	O	8	OBJ	O
O	O	1792	1794	in	in	B-PP	IN	O	8	VMOD	O
O	O	1795	1798	the	the	B-NP	DT	O	14	NMOD	O
O	O	1799	1809	activation	activation	I-NP	NN	O	12	PMOD	O
O	O	1810	1812	of	of	B-PP	IN	O	14	NMOD	O
O	O	1813	1816	the	the	B-NP	DT	O	21	NMOD	O
O	O	1817	1822	human	human	I-NP	JJ	B-DNA	21	NMOD	B-DNA
T15	B-Protein	1823	1826	TNF	TNF	I-NP	NN	I-DNA	21	NMOD	I-DNA
T15	I-Protein	1826	1827	-	-	O	HYPH	I-DNA	21	NMOD	I-DNA
T15	I-Protein	1827	1832	alpha	alpha	O	SYM	I-DNA	21	NMOD	I-DNA
O	O	1833	1837	gene	gene	B-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	1838	1841	and	and	O	CC	O	8	VMOD	O
O	O	1842	1850	proposes	propose	B-VP	VBZ	O	8	VMOD	O
O	O	1851	1852	a	a	B-NP	DT	O	26	NMOD	O
O	O	1853	1856	new	new	I-NP	JJ	O	26	NMOD	O
O	O	1857	1866	mechanism	mechanism	I-NP	NN	O	23	OBJ	O
O	O	1867	1869	to	to	B-VP	TO	O	28	VMOD	O
O	O	1870	1877	control	control	I-VP	VB	O	26	NMOD	O
T16	B-Protein	1878	1881	TNF	TNF	B-NP	NN	B-protein	33	NMOD	B-protein
T16	I-Protein	1881	1882	-	-	B-NP	HYPH	O	33	NMOD	O
T16	I-Protein	1882	1887	alpha	alpha	I-NP	SYM	O	33	NMOD	O
O	O	1888	1892	gene	gene	I-NP	NN	O	33	NMOD	O
O	O	1893	1903	expression	expression	I-NP	NN	O	28	OBJ	O
O	O	1903	1904	.	.	O	.	O	5	P	O
